Alere Inc.(医療機器分野):企業M&A動向

調査会社GlobalData社が発行したリサーチレポート(データ管理コード:GDME361D)
◆英語タイトル:Alere Inc. - Medical Equipment - Deals and Alliances Profile
◆発行会社/調査会社:GlobalData
◆商品コード:GDME361D
◆発行日:2014年5月5日
◆調査対象地域:アメリカ
◆ページ数:126
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Alere Inc.(医療機器分野):企業M&A動向]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Summary

Alere Inc. (Alere), (formerly Inverness Medical Innovations, Inc.) is one of the leading providers of point-of-care diagnostics solutions and services. Its solutions and services enable patients to take charge of their own health at home and allow healthcare providers and payors to enhance care, prevent disease advancement and reduce healthcare costs. The company provides near-patient monitoring tools and value-added healthcare services. Its products and services focus on cardiology, women’s health, infectious diseases, diabetes, oncology, and toxicology. Its portfolio portfolio also includes a broad array of health information solutions which increase access to critical health data, provide clinical decision support, and facilitate augmented performance reporting and analysis. Its major customers include hospitals, reference laboratories, point-of-care settings, self-insured employees, wholesale and retail drug stores, and mass merchandisers spread across various countries throughout the world. The company operates through its subsidiaries in the Americas, Europe, the Middle East, Asia-Pacific, and Africa. Alere is headquartered in Waltham, Massachusetts, the US.

Alere Inc. – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

*** レポート目次(コンテンツ)***

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Alere Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 7
Alere Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 8
Alere Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 9
Alere Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 10
Alere Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 11
Alere Inc., Medical Equipment, Deal Details 15
Asset Purchase 15
Axis-Shield Acquires Global Clinical Chemistry Homocysteine Business From Catch 15
Inverness Medical Innovations Acquires Immunoassay Diagnostics Business Of ACON Labs 16
Axis-Shield Acquires German Distribution Rights From PROGEN Biotechnik 17
Venture Financing 19
eScreen Raises US$26.9 Million In Venture Financing 19
Quotient Diagnostics Secures US$1.99 Million In Financing 20
eScreen Raises Funds Through Venture Financing 21
eScreen Raises US$8 Million In Venture Financing 22
Partnerships 23
Alere Exercises Option For Licensing Agreement With Miraculins For Endoglin Products 23
VitaPath Genetics Enters Into Licensing Agreement With Alere 25
Hycor Biomedical Signs Licensing Agreement With Axis-Shield 26
Thermo Fisher Scientific Enters Into Licensing Agreement With Alere 27
Alere Enters Into Licensing Agreement With Roche Diagnostics 28
Roche Diagnostics Enters Into Licensing Agreement With Alere 29
OraSure Technologies Signs Licensing Agreement With Inverness Medical Innovations 30
Hansa Medical Enters Into An Agreement With Axis-Shield 31
Alere Enters Into Co-Development Agreement With AT&T 32
Axis-Shield Enters Into Co-Development Agreement With Siemens Healthcare Diagnostics 33
EKF Diagnostics Enters Into Distribution Agreement With Alere 34
Spartan Bioscience Enters Into Distribution Agreement With Alere 35
Axis-Shield Signs Option Agreement With Bio-Rad Labs 36
Systagenix Wound Management Enters Into Co-Development Agreement With Alere 37
Laboratorios Rubio Enters Into Distribution Agreement With Alere Healthcare 38
Gold Standard Diagnostics Enters Into An Agreement With Axis-Shield 39
AnaSpec Enters Into Distribution Agreement With Bioeasy Diagnostica 40
BG Medicine Enters Into An Agreement With Inverness Medical Innovations 41
Axis-Shield Enters Into An Agreement With Abbott Labs 42
FIND Enters Into Agreement With Standard Diagnostics 43
Myconostica Enters Into Distribution Agreement With Inverness Medical Canada 44
Miraculins Enters Into An Agreement With Inverness Medical Innovations 45
Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 46
Mobidiag Enters Into Distribution agreement With Inverness Medical Deutschland 47
Lab21 Enters Into Distribution Agreement With AdnaGen 48
Blanchette Rockefeller Neurosciences Institute Signs An Agreement With Inverness Medical Innovations 49
Mediwatch Enters Into An Agreement With Inverness Medical Innovations 50
Sysmex Europe Enters Into An Agreement with AdnaGen 51
Axis-Shield Enters Into An Agreement With Beckman Coulter 52
Axis-Shield Enters Into Co-Development Agreement With Abbott 53
Inverness Medical Innovations Enters Into An Agreement With PrognostiX 54
Abbott Labs Extends Its Distribution Agreement With Axis-Shield 55
Alere Extends Cardiology Products Distribution Agreement With Thermo Fisher Scientific 56
Inverness Medical Innovations Forms Joint Venture With Private Equity Groups 57
AdnaGen Extends Licensing Agreement With KellBenx 58
BioCurex Enters Into Licensing Agreement With Inverness 59
Debt Offering 60
Alere Completes Private Placement Of Notes Due 2020 For US$425 Million 60
Alere Completes Private Placement Of Notes Due 2018 For US$450 Million 62
Alere Completes Private Placement Of Senior Subordinate Notes For US$400 Million 64
Inverness Medical Innovations Completes Private Placement Of Senior Notes For US$100 Million 65
Inverness Medical Innovations Completes Public Offering Of 7.88% Senior Notes For US$150 Million 66
Inverness Medical Innovations Completes Public Offering Of 9% Senior Subordinated Notes For US$400 Million 67
Acquisition 68
Alere Completes Acquisition Of Epocal For Up To US$241 Million 68
Alere Completes Acquisition Of eScreen For US$296 Million 70
Arriva Medical Acquires AmMed Direct For US$23 Million 72
Arriva Medical Acquires Direct Diabetic Source 73
Alere Completes Acquisition Of Medical Automation System 74
Alere Acquires Arriva Medical From Palm Beach Capital For US$83 Million 75
Alere Completes Acquisition Of Axis-Shield, Diagnostic Test Maker, For US$389 Million 76
Alere Acquires Lab Data Systems 78
Alere Holdings Bermuda Acquires 78% Stake Of AdnaGen From OncoVista Innovative Therapies 79
EKF Diagnostics Acquires Quotient Diagnostics 81
Inverness Medical Innovations Acquires 78.13% Stake In Standard Diagnostics 83
Inverness Medical Innovations To Acquire Kroll Lab Specialists From Kroll 85
Inverness Medical Innovations Completes Acquisition Of Concateno From Marwyn 86
Lab21 Acquires Plasmatec Lab Products From Axis-Shield 88
FIR Capital Partners Sells Stake In Prodimol Biotecnologia To Orgenics 89
Inverness Medical Innovations Acquires Biosystems 90
Inverness Medical Innovations Acquires Vision Biotech 91
Inverness Medical Innovations Acquires Global Diagnostics 92
Inverness Medical Innovations Acquires DiaTeam 93
OncoVista Innovative Therapies Increases Stake In AdnaGen 94
Inverness Medical Innovations Acquires Matria Healthcare 95
Inverness Medical Innovations Acquires BBI Holdings 97
Inverness Medical Innovations Acquires Panbio 99
Alere Inc. – Key Competitors 100
Key Employees 101
Locations And Subsidiaries 103
Head Office 103
Other Locations & Subsidiaries 103
Recent Developments 110
Financial Announcements 110
Apr 29, 2014: Alere Announces First Quarter 2014 Results 110
Feb 06, 2014: Alere Announces Fourth Quarter 2013 Results 111
Dec 11, 2013: Alere Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock 112
Oct 22, 2013: Alere Schedules Conference Call for 8:30 a.m. ET October 29, 2013 to Discuss Third Quarter 2013 Results 112
Sep 03, 2013: Alere Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock 113
Jul 31, 2013: Alere Inc. Announces Second Quarter 2013 Results 113
May 09, 2013: Alere Reports Revenue Of $735.2m In Q1 2013 114
Feb 15, 2013: Alere Reports Revenue Of $2.8m In 2012 115
Corporate Communications 116
Dec 12, 2013: Dr. Regina Benjamin Joins Alere Board 116
Aug 22, 2013: Alere Enhances Board of Directors With Appointment Of Gregg J. Powers 117
Legal and Regulatory 117
Sep 16, 2013: Early Adopters Receive NCQA Case Management Accreditation 117
Government and Public Interest 118
Jan 07, 2014: Alere to Attend the 32nd Annual J.P. Morgan Healthcare Conference on January 16th, 2014 118
Product News 118
Jan 23, 2014: First Rapid Molecular Diagnostic Test to Detect Influenza A and B Virus in Under 15 Minutes Now Available in Europe on the Alere i Platform 118
Oct 29, 2013: First rapid diagnostic test to detect both HIV-1 antigen and HIV-1/2 antibodies now available 119
Sep 23, 2013: Alere Partners With Malaria No More On Power Of One Campaign In The Fight Against Malaria 119
Aug 08, 2013: US FDA approves diagnostic test to detect HIV-1 antigen, HIV-1/2 antibodies 120
Aug 05, 2013: Alere MobileLink Receives FDA Clearance 120
Apr 23, 2013: Alere Announces Publication Of HABIT Pilot Study Results For Home BNP Testing 121
Mar 11, 2013: Alere Presents Five-Year STOP-HF Study Results At American College of Cardiology’s 62nd Annual Scientific Session 121
Product Approvals 122
Aug 08, 2013: US FDA approves diagnostic test to detect HIV-1 antigen, HIV-1/2 antibodies 122
Aug 05, 2013: Alere MobileLink Receives FDA Clearance 123
Clinical Trials 123
Mar 11, 2013: Alere Presents Five-Year STOP-HF Study Results At American College of Cardiology’s 62nd Annual Scientific Session 123
Other Significant Developments 124
Mar 03, 2014: Alere Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock 124
Feb 19, 2013: Triad HealthCare Network Selects Alere’s Accountable Care Solutions For Fast And Secure Health Information Exchange 124
Appendix 126
Methodology 126
About GlobalData 126
Contact Us 126
Disclaimer 126

List of Tables
Alere Inc., Medical Equipment, Key Facts, 2013 1
Alere Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 1
Alere Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 1
Alere Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 1
Alere Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 1
Alere Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 7
Alere Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 8
Alere Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 9
Alere Inc., Deals By Market, 2008 to YTD 2014 10
Alere Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 11
Axis-Shield Acquires Global Clinical Chemistry Homocysteine Business From Catch 15
Inverness Medical Innovations Acquires Immunoassay Diagnostics Business Of ACON Labs 16
Axis-Shield Acquires German Distribution Rights From PROGEN Biotechnik 17
eScreen Raises US$26.9 Million In Venture Financing 19
Quotient Diagnostics Secures US$1.99 Million In Financing 20
eScreen Raises Funds Through Venture Financing 21
eScreen Raises US$8 Million In Venture Financing 22
Alere Exercises Option For Licensing Agreement With Miraculins For Endoglin Products 23
VitaPath Genetics Enters Into Licensing Agreement With Alere 25
Hycor Biomedical Signs Licensing Agreement With Axis-Shield 26
Thermo Fisher Scientific Enters Into Licensing Agreement With Alere 27
Alere Enters Into Licensing Agreement With Roche Diagnostics 28
Roche Diagnostics Enters Into Licensing Agreement With Alere 29
OraSure Technologies Signs Licensing Agreement With Inverness Medical Innovations 30
Hansa Medical Enters Into An Agreement With Axis-Shield 31
Alere Enters Into Co-Development Agreement With AT&T 32
Axis-Shield Enters Into Co-Development Agreement With Siemens Healthcare Diagnostics 33
EKF Diagnostics Enters Into Distribution Agreement With Alere 34
Spartan Bioscience Enters Into Distribution Agreement With Alere 35
Axis-Shield Signs Option Agreement With Bio-Rad Labs 36
Systagenix Wound Management Enters Into Co-Development Agreement With Alere 37
Laboratorios Rubio Enters Into Distribution Agreement With Alere Healthcare 38
Gold Standard Diagnostics Enters Into An Agreement With Axis-Shield 39
AnaSpec Enters Into Distribution Agreement With Bioeasy Diagnostica 40
BG Medicine Enters Into An Agreement With Inverness Medical Innovations 41
Axis-Shield Enters Into An Agreement With Abbott Labs 42
FIND Enters Into Agreement With Standard Diagnostics 43
Myconostica Enters Into Distribution Agreement With Inverness Medical Canada 44
Miraculins Enters Into An Agreement With Inverness Medical Innovations 45
Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 46
Mobidiag Enters Into Distribution agreement With Inverness Medical Deutschland 47
Lab21 Enters Into Distribution Agreement With AdnaGen 48
Blanchette Rockefeller Neurosciences Institute Signs An Agreement With Inverness Medical Innovations 49
Mediwatch Enters Into An Agreement With Inverness Medical Innovations 50
Sysmex Europe Enters Into An Agreement with AdnaGen 51
Axis-Shield Enters Into An Agreement With Beckman Coulter 52
Axis-Shield Enters Into Co-Development Agreement With Abbott 53
Inverness Medical Innovations Enters Into An Agreement With PrognostiX 54
Abbott Labs Extends Its Distribution Agreement With Axis-Shield 55
Alere Extends Cardiology Products Distribution Agreement With Thermo Fisher Scientific 56
Inverness Medical Innovations Forms Joint Venture With Private Equity Groups 57
AdnaGen Extends Licensing Agreement With KellBenx 58
BioCurex Enters Into Licensing Agreement With Inverness 59
Alere Completes Private Placement Of Notes Due 2020 For US$425 Million 60
Alere Completes Private Placement Of Notes Due 2018 For US$450 Million 62
Alere Completes Private Placement Of Senior Subordinate Notes For US$400 Million 64
Inverness Medical Innovations Completes Private Placement Of Senior Notes For US$100 Million 65
Inverness Medical Innovations Completes Public Offering Of 7.88% Senior Notes For US$150 Million 66
Inverness Medical Innovations Completes Public Offering Of 9% Senior Subordinated Notes For US$400 Million 67
Alere Completes Acquisition Of Epocal For Up To US$241 Million 68
Alere Completes Acquisition Of eScreen For US$296 Million 70
Arriva Medical Acquires AmMed Direct For US$23 Million 72
Arriva Medical Acquires Direct Diabetic Source 73
Alere Completes Acquisition Of Medical Automation System 74
Alere Acquires Arriva Medical From Palm Beach Capital For US$83 Million 75
Alere Completes Acquisition Of Axis-Shield, Diagnostic Test Maker, For US$389 Million 76
Alere Acquires Lab Data Systems 78
Alere Holdings Bermuda Acquires 78% Stake Of AdnaGen From OncoVista Innovative Therapies 79
EKF Diagnostics Acquires Quotient Diagnostics 81
Inverness Medical Innovations Acquires 78.13% Stake In Standard Diagnostics 83
Inverness Medical Innovations To Acquire Kroll Lab Specialists From Kroll 85
Inverness Medical Innovations Completes Acquisition Of Concateno From Marwyn 86
Lab21 Acquires Plasmatec Lab Products From Axis-Shield 88
FIR Capital Partners Sells Stake In Prodimol Biotecnologia To Orgenics 89
Inverness Medical Innovations Acquires Biosystems 90
Inverness Medical Innovations Acquires Vision Biotech 91
Inverness Medical Innovations Acquires Global Diagnostics 92
Inverness Medical Innovations Acquires DiaTeam 93
OncoVista Innovative Therapies Increases Stake In AdnaGen 94
Inverness Medical Innovations Acquires Matria Healthcare 95
Inverness Medical Innovations Acquires BBI Holdings 97
Inverness Medical Innovations Acquires Panbio 99
Alere Inc., Key Competitors 100
Alere Inc., Key Employees 101
Alere Inc., Other Locations 103
Alere Inc., Subsidiaries 103

List of Figures
Alere Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 1
Alere Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 7
Alere Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 8
Alere Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 9
Alere Inc., Medical Equipment, Deals by Market, 2008 to YTD 2014 10

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 電解マンガンの世界市場予測2018-2023
    Electrolytic manganese dioxide is one of the critical components of modern batteries. Increase in demand for electrolytic manganese dioxide in lithium ion batteries and extensive use of electrolytic manganese dioxide in zinc-carbon batteries are some of the key factors driving the electrolytic manga …
  • 出力アイソレータの世界市場2021
    Notes:Production, means the output of Output Isolators Revenue, means the sales value of Output Isolators This report studies Output Isolators in Global market, especially in North America, Europe, China, Japan, Korea and Taiwan, focuses on top manufacturers in global market, with Production, price, …
  • カナダの建設機械市場
    This report is the result of Timetric’s extensive market research covering the construction equipment market in Canada. It contains detailed data on market dynamics along with latest industry happenings, industry players and happening projects in Canada. "Canada Construction Equipment Market Update" …
  • 世界のフライアッシュ制御市場2017
    Fly Ash Control Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, German …
  • 工業用PCの世界市場
    In this report, the global Industrial Grade PC market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, reven …
  • Database of Sugar Manufacturers(製糖メーカー調査資料) in China
    This company database includes the details of nearly 200 sugar manufacturers in China. The database contains the following information about the companies: Company name Contact details Contact persons Financial information Number of employees The database is essential for companies who want to find …
  • オマーンの液圧タービン及びウオーターホイール市場(規模、トレンド、予測~2018年)
    The industry data report, Hydraulic Turbine and Water Wheel Market in Oman to 2018 - Market Size, Trends, and Forecasts, offers the most up-to-date market data on the actual market size, trends and future outlook for hydraulic hydraulic turbine and water wheels and water wheels in Oman. This researc …
  • 補助セメント材料の世界市場
    Supplementary Cementitious Materials Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries ( …
  • フランスの電子部品市場(市場規模、トレンド、2017年までの予測、企業):Electronic Component Market in France to 2017 – Market Size, Trends, and Forecasts, and Market Players
    The industry report Electronic Component Market in France to 2017 - Market Size, Trends, Forecasts, and Market Players offers the most up-to-date perspective on the actual market situation, trends, and future outlook for electronic components in France. This study includes historic market data from …
  • 南米の脊椎非固定術(医療機器)市場分析・予測
    Spinal Non-fusion - South American Analysis and Market Forecasts Summary The promise of spinal non-fusion technologies, while initially large during its infancy, has tapered somewhat with challenges developing in specific non-fusion device segments due to insufficient evidence of clinical efficacy. …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDME361D )"Alere Inc.(医療機器分野):企業M&A動向" (英文:Alere Inc. - Medical Equipment - Deals and Alliances Profile)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。